Abnormally High Neuronal Density in the Schizophrenic Cortex: A Morphometric Analysis of Prefrontal Area 9 and Occipital Area 17

Archives of General Psychiatry

Volumn 52, Issue 10, 1995, Pages 805-818

  Selemon, Lynn D ^a   Rajkowska, Grazyna ^a,b   Goldman Rakic, Patricia S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; BRAIN REGION; BRAIN SIZE; CELL DENSITY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INFORMATION PROCESSING; MORPHOMETRICS; SCHIZOPHRENIA;

ADULT; AGED; ATROPHY; CELL COUNT; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLIOSIS; HUMAN; HUNTINGTON DISEASE; MALE; MIDDLE AGE; NEURONS; OCCIPITAL LOBE; PREFRONTAL CORTEX; PSYCHOTIC DISORDERS; PYRAMIDAL CELLS; SCHIZOPHRENIA; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028825345     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1995.03950220015005     Document Type: Article

References (82)

1. Kraepelin E; Barclay RM, Robertson GN, trans. Dementia Praecox and Paraphrenia. New York, NY: RE Krieger Publishing Co; 1907.
2. Alzheimer A. Beitrage zur pathologischen Anatomie der Dementia Praecox. Allg Z Psychiatrie. 1913;70: 810–812.
3. Ingvar DH. Abnormal distribution of cerebral activity in chronic schizophrenia: a neurophysiological interpretation. In: Baxter C, Melnechuk T, eds. Perspectives in Schizophrenia. New York, NY: Raven Press; 1980:107.
4. Levin S. Frontal lobe dysfunctions in schizophrenia, II: impairments of psychological and brain functions. J Psychiatry Res. 1984;18: 27–55.
5. Zec RF, Weinberger DR. Brain areas implicated in schizophrenia: a selective overview. In: Nasrallah HA, Weinberger DR, eds. Handbook of Schizophrenia. New York, NY: Elsevier Science Publishers BV; 1986;1: 175–206.
6. Goldman-Rakic PS. Prefrontal cortical dysfunction in schizophrenia: the relevance of working memory. In: Carroll BJ, Barrett JE, eds. Psychopathology and the Brain. New York, NY: Raven Press; 1991: 1–23.
7. Ingvar DH, Franzen G. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr Scand. 1974;50: 425–462.
8. Buchsbaum MS, Ingvar DH, Kessler R, Waters RN, Cappelletti J, van Kammen DP, King AC, Johnson JJ, Manning RG, Flynn RM, Mann LS, Bunney WE Jr, Sokoloff L. Cerebral glucography with positron tomography in normals and in patients with schizophrenia. Arch Gen Psychiatry. 1982;39: 251–259.
9. Buchsbaum MS, DeLisi LE, Holcomb HH, Cappelletti J, King AC, Johnson J, Hazlett E, Dowling-Zimmerman S, Post RM, Morihisa J, Carpenter W, Cohen R, Pickar D, Weinberger DR, Margolin R, Kessler RM. Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Arch Gen Psychiatry. 1984;41: 1159–1166.
10. Ariel RN, Golden CJ, Berg RA, Quaife MA, Dirkson JW, Forsell T, Wilson J, Graber B. Regional cerebral blood flow in schizophrenics. Arch Gen Psychiatry. 1883;40: 258–263.
11. Farkas T, Wolf AP, Jaeger J, Brodie JD, Christman DR, Fowler JS. Regional brain glucose metabolism in chronic schizophrenia: a positron emission transaxial tomographic study. Arch Gen Psychiatry. 1984;41: 293–300.
12. Kurachi M, Kobayashi K, Matsubara R, Hiramatsu H, Yamaguchi N, Matsuda H, Maeda T, Hisada K. Regional cerebral blood flow in schizophrenic disorders. Eur Neurol. 1985;24: 176–181.
13. Chabrol H, Guell A, Bes A, Moron P. Cerebral blood flow in schizophrenic adolescents. Am J Psychiatry. 1986;143:130.
14. Guenther W, Moser E, Mueller-Spahn F, von Oefele K, Buell U, Hippius H. Pathological cerebral blood flow during motor function in schizophrenic and endogenous depressed patients. Biol Psychiatry. 1986;21: 889–899.
15. Volkow ND, Wolf AP, van Gelder P, Brodie P, Overall JE, Cancro R, Gomez-Mont F. Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia. Am J Psychiatry. 1987;144: 151–158.
16. Mathew RJ, Wilson WH, Tant SR, Robinson L, Prakash R. Abnormal resting regional cerebral blood flow patterns and their correlates in schizophrenia. Arch Gen Psychiatry. 1988;45: 542–549.
17. Wolkin A, Angrist B, Wolf A, Brodie JD, Wolkin B, Jaeger J, Cancro R, Rotrosen J. Low frontal glucose utilization in chronic schizophrenia: a replication study. Am J Psychiatry. 1988;145: 251–253.
18. Paulman RG, Devous MD, Gregory RR, Herman JH, Jennings L, Bonte FJ, Nasrallah HA, Raese JD. Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function. Biol Psychiatry. 1990;27: 377–399.
19. Sagawa K, Kawakatsu S, Shibuya I, Oiji A, Morinobu S, Komatani A, Yazaki M, Totsuka S. Correlation of regional cerebral blood flow with performance on neuropsychological tests in schizophrenic patients. Schizophr Bull. 1990;3: 241–246.
20. Goldman-Rakic PS. Circuitry of the prefrontal cortex and the regulation of behavior by representational memory. In: Plum F, Mountcastle V, eds. Handbook of Physiology. Bethesda, Md: American Physiological Society; 1987;5(pt 1): 373–417.
21. Devous MD Sr, Raese JD, Herman JH, Paulman RG, Gregory RR, Rush AJ, Chehabi HH, Bonte FJ. Regional cerebral blood flow in schizophrenic patients at rest and during Wisconsin Card Sort tasks. J Cereb Blood Flow Metab. 1985;5(suppl 1):S201-S202.
22. Berman KF, Zec RF, Weinberger DR. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia, II: role of neuroleptic treatment, attention, and mental effort. Arch Gen Psychiatry. 1986;43: 126–135.
23. Weinberger DR, Berman KF, Zec RF. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia, I: regional cerebral blood flow (rCBF) evidence. Arch Gen Psychiatry. 1986;43: 114–124.
24. Weinberger DR, Berman KF, II Iowsky BP. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia, III: a new cohort and evidence for a monoaminergic mechanism. Arch Gen Psychiatry. 1988;45: 609–615.
25. Buchsbaum MS, Nuechterlein KH, Haier RJ, Wu J, Sicotte N, Hazlett E, Asarnow R, Potkin S, Guich S. Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography. Br J Psychiatry. 1990;156: 216–227.
26. Andreasen NC, Rezai K, Alliger R, Swayze VW II, Flaum M, Kirchner P, Cohen G, O'Leary DS. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia: assessment with xenon 133 single-photon emission computed topography and the Tower of London. Arch Gen Psychiatry. 1992;49: 943–958.
27. Benes FM, Davidson J, Bird ED. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry. 1986;43: 31–35.
28. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry. 1991;48: 996–1001.
29. Akbarian S. Kim JJ., Tafazolli A., Hagman JO., Potkin SG., Bunney WE Jr., Jones EG. Altered neurocellular composition of prefrontal cortex in schizophrenia. Soc Neurosci Abstr. 1993;19:200. Abstract.
30. Abercrombie M. Estimation of nuclear population from microtome sections. Anat Rec. 1946;94: 239–247.
31. Williams RW, Rakic P. Three-dimensional counting: an accurate and direct method to estimate numbers of cells in sectioned material. J Comp Neurol. 1988;278: 344–352.
32. Fedio P, Cox CS, Neophytides A, Canal-Frederick G, Chase TN. Neuropsychological profile of Huntington's disease: patients and those at risk. Adv Neurol. 1979;23: 239–255.
33. Weinberger DR., Berman KF., Ladarola M., Driesen N., Zec RF. Prefrontal cortical blood flow and cognitive function in Huntington's disease. J Neurol Neurosurg Psychiatry. 1988;51: 94–104.
34. Feigner JP, Robins E, Guze SB, Woodruff RA, Winokur G, Munoz R. Diagnostic criteria for psychiatric research. Arch Gen Psychiatry. 1972;26: 57–63.
35. Rajkowska G, Goldman-Rakic PS. Cytoarchitectonic definition of prefrontal areas in the normal human cortex, I: remapping of areas 9 and 46 using quantitative criteria. Cereb Cortex. 1995;5: 307–322.
36. Rajkowska G, Goldman-Rakic PS. Cytoarchitectonic definition of prefrontal areas in the normal human cortex, II: variability in locations of areas 9 and 46 and relationship to the Talairach coordinate system. Cereb Cortex. 1995;5: 323–337.
37. Rajkowska G, Selemon LD, Goldman-Rakic PS. Reduction in neuronal sizes in prefrontal cortex of schizophrenics and Huntington patients. Schizophr Res. 1995;15:31. Abstract.
38. Terry RD, DeTeresa R, Hansen LA. Neocortical cell counts in normal human adult aging. Ann Neurol. 1987;21: 530–539.
39. Jernigan TL, Press GA, Hesselink JR. Methods for measuring brain morphologic features on magnetic resonance images: validation and normal aging. Arch Neurol. 1990;47: 27–32.
40. Coffey CE, Wilkinson WE, Parashos IA, Soady SAR, Sullivan RJ, Patterson LJ, Figiel GS, Webb MC, Spritzer CE, Djang WT. Quantitative cerebral anatomy of the aging human brain: a cross-sectional study using magnetic resonance imaging. Neurology. 1992;42: 527–536.
41. DeLisi LE, Goldin LR, Maxwell ME, Kazuba DM, Gershon ES. Clinical features of illness in siblings with schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 1987;44: 891–896.
42. Schulsinger F, Parnas J, Mednick S, Teasdale TW, Schulsinger H. Heredityenvironment interaction and schizophrenia. J Psychiatr Res. 1987;21: 431–436.
43. Cannon TD, Mednick SA, Parnas J, Schulsinger F, Praestholm J, Vestergaard A. Developmental brain abnormalities in the offspring of schizophrenic mothers. Arch Gen Psychiatry. 1993;50: 551–564.
44. Coryell W, Zimmerman M. The heritability of schizophrenia and schizoaffective disorder: a family study. Arch Gen Psychiatry. 1988;45: 323–327.
45. Harrow M, Grossman LS. Outcome in schizoaffective disorders: a critical review and reevaluation of the literature. Schizophr Bull. 1984;10: 87–108.
46. Rajkowska G, Selemon LD, Goldman-Rakic PS. Reduction in neuronal sizes in prefrontal cortex of schizophrenics and Huntington patients. Soc Neurosci Abstr. 1994;20:620. Abstract.
47. Goldman-Rakic PS, Lidow M, Gallager DW. Overlap of dopaminergic, adrenergic, and serotinergic receptor and complementarity of their subtypes in the primate prefrontal cortex. J Neurosci. 1990;10: 2125–2138.
48. Vonsattel J-P, Myers RH, Stevens TJ, Ferrante RJ. Bird ED, Richardson EP Jr. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol. 1985;44: 559–577.
49. Rajkowska G, Selemon LD, Goldman-Rakic PS. Morphometric evidence for prefrontal cellular atrophy in advanced Huntington's disease. Soc Neurosci Abstr. 1993;19:838. Abstract.
50. Jibiki I, Takizawa Y, Yamaguchi N. Visual dysfunction in treated schizophrenia suggested by visual evoked potentials from pattern-reversal stimulation. Eur Psychiatry Clin Neurosci. 1991;241: 61–64.
51. Lewis SW, Ford RA, Syed GM, Reveley AM, Toone BK. A controlled study of 99mTc-HMPAO single-photon emission imaging in chronic schizophrenia. Psychol Med. 1992;22: 27–33.
52. Javitt DC, Doneshka P, Zylberman I, Ritter W, Vaughan HG Jr. Impairment of early cortical processing in schizophrenia: an event related potential confirmation study. Biol Psychiatry. 1993;33: 513–519.
53. Renshaw PF, Yurgellen-Todd DA, Cohen BM. Greater hemodynamic response to photic stimulation in schizophrenic patients: an echo-planar MRI study. Am J Psychiatry. 1994;151: 1493–1495.
54. Grove WM, Clementz BA, Iacono WG, Katsanis J. Smooth pursuit ocular motor dysfunction in schizophrenia: evidence for a major gene. Am J Psychiatry. 1992;149: 1362–1368.
55. Holzman PS. Behavioral markers of schizophrenia useful for genetic studies. J Psychiatry Res. 1992;26: 427–445.
56. Benes FM, Vincent SL, Alsterberg G, Bird ED, SanGiovanni JP. Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci. 1992;12: 924–929.
57. Bunney WE Jr, Akbarian S, Kim JJ, Hagman JO, Potkin SG, Jones EG. Gene expression for glutamic acid decarboxylase is reduced in prefrontal cortex of schizophrenics. Soc Neurosci Abstr. 1993;19:199. Abstract.
58. Daviss SR, Lewis DA. Calbindin- and calretinin-immunoreactive local circuit neurons are increased in density in the prefrontal cortex of schizophrenic subjects. Soc Neurosci Abstr. 1993;19:201. Abstract.
59. Akbarian S, Bunney WE Jr, Potkin SG, Wigal SB, Hagman JO, Sandman CA, Jones EG. Altered distribution of nicotinamide-adenine dinucleotide phosphatediaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry. 1993;50: 169–177.
60. Pakkenberg B. Total nerve cell number in neocortex in chronic schizophrenic and controls estimated using optical disectors. Biol Psychiatry. 1993;34: 768–772.
61. Brown R, Colter N, Corsellis JAN, Crow TJ, Frith CD, Jagoe R, Johnstone EC, Marsh L. Postmortem evidence of structural brain changes in schizophrenia: differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. Arch Gen Psychiatry. 1986;43: 36–42.
62. Shiraishi H, Koizume J, Ofudu K, Suzuki T, Saito K, Hori T, Ikuta T, Kase K, Hori M. Enlargement of the anterior horn of the lateral ventricle in schizophrenic pateints: chronological and morphometrical studies. Jpn J Psychiatry. 1990;44: 693–702.
63. McCarley RW, Shenton ME, O'Donnell BF, Faux SF, Kikinis R, Nestor PG, Jolesz FA. Auditory P300 abnormalities and left posterior superior temporal gyrus. Arch Gen Psychiatry. 1993;50: 190–197.
64. Kelsoe JR Jr, Cadet JL, Pickar D, Weinberger DL. Quantitative neuroanatomy in schizophrenia: a controlled magnetic resonance imaging study. Arch Gen Psychiatry. 1988;45: 533–541.
65. Breier A, Buchanan RW, Elkashef A, Munson RC, Kirkpatrick B, Gellad F. Brain morphology and schizophrenia: a magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch Gen Psychiatry 1992;49: 921–926.
66. Raine A, Lencz T, Reynolds GP, Harrison G, Sheard C, Medley I, Reynolds LM, Cooper JE. An evaluation of structural and functional prefrontal deficits in schizophrenia: MRI and neuropsychological measures. Psychiatr Res Neuroimaging. 1992;45: 123–137.
67. Zipursky RB, Lim KO, Sullivan EV, Brown BW, Pfefferbaum A. Widespread cerebral gray matter volume deficits in schizophrenia. Arch Gen Psychiatry. 1992;42: 195–205.
68. Friedman L, Knudsen L, Shurell M, Meltzer HY. Prefrontal sulcal prominence is inversely related to response to clozapine. Biol Psychiatry. 1993;33: 513–519.
69. Andreasen NC, Flashman L, O'Leary DS, Flaum M, Swayze V. Decreased frontal lobe size in schizophrenia measured with volumetric magnetic resonance (MR) imaging. Soc Neurosci Abstr. 1994;20:24. Abstract.
70. Shelton RC, Karson CN, Doran AR, Pickar D, Bigelow LB, Weinberger DR. Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defect. Am J Psychiatry. 1988;145: 154–163.
71. Doran AR, Boronow J, Weinberger DR, Wolkowitz OM, Breier A, Pickar D. Structural brain pathology in schizophrenia revisited: prefrontal cortex pathology is inversely correlated with cerebrospinal fluid levels of homovanillic acid. Neuropsychopharmacology. 1987;1: 25–32.
72. Lieberman J, Bogerts B, Degreef G, Ashtari M, Lantos G, Alvir J. Qualitative assessment of brain morphology in acute and chronic schizophrenia. Am J Psychiatry. 1992;149: 784–794.
73. Pettegrew JW, Keshavan MS, Panchalingam K, Strychor S, Kaplan DB, Tretta MG, Allen M. Alterations in brain high-energy phosphate and membraine phospholipid metabolism in first-episode, drug-naive schizophrenics: a pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Arch Gen Psychiatry. 1991;48: 563–568.
74. Fujimoto T, Nakano T, Takano T, Hokazono Y, Asakura T, Tsuji T. Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging. Acta Psychiatr Scand. 1992;86: 455–462.
75. Pettegrew JW, Keshavan MS, Minshew NJ. 31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia. Schizophr Bull. 1993;19: 35–53.
76. Glantz LA, Lewis DA. Synaptophysin immunoreactivity is selectively decreased in the prefrontal cortex of schizophrenic subjects. Soc Neurosci Abstr. 1993;19:201. Abstract.
77. Payne BR, Conners C, Cornwell P. Survival and death of neurons in cortical area PMLS after removal of areas 17, 18 and 19 in cats and kittens. Cereb Cortex. 1991;1: 469–491.
78. Haug H, Kuhl S, Mecke E, Sass N-L, Wasner K. The significance of morphometric procedures in the investigation of age changes in cytoarchitectonic structures of human brain. J Hirnforschung. 1984;25: 353–374.
79. Haug H, Eggers R. Morphometry of the human cortex cerebri and corpus striatum during aging. Neurobiol Aging. 1991;12: 336–338.
80. Algan O, Goldman-Rakic PS, Rakic P. Selective laminar and areal deletion of cortical neurons by prenatal x-irradiation in the macaque monkey. Soc Neurosci Abstr. 1992;17:1146. Abstract.
81. Pakkenberg B. Pronounced reduction of nerve cell number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. J Neurol Neurosurg Psychiatry. 1990;47: 1023–1028.
82. Andreasen NC, Arndt S, Swayze V II, Cizadlo T, Flaum M, O'Leary D, Ehrhardt JC, Yuh WTC. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science. 1994;266: 294–298.